S 898 · 117th Congress

Fair Accountability and Innovative Research Drug Pricing Act of 2021

<p><b>Fair Accountability and Innovative Research Drug Pricing Act of 20</b><strong>21</strong><strong></strong></p> <p>This bill requires manufacturers to report about certain price increases for prescription drugs and biological products with a wholesale cost of at least $100 per month. Such reports must include,…

Sponsor

Baldwin, Tammy (D-WI)

Introduced

2021-03-23

Policy area

Health

Latest action

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.